_:neb3ddfe05e674592bea544e0af56563exb0
<http://schema.org/description>
"Register now to reserve your seat for this multidisciplinary virtual roundtable on advances in clinical trial endpoints collection for Parkinson's disease.\r\nDuring this roundtable, a panel of clinicians and scientists will review advancements in imaging modalities and the expansion of wearable sensors for instrumented performance outcome, and the collection of digital clinical trial endpoints for Parkinson’s disease trials. Examples will include how these approaches generate richer data and clinically meaningful outcomes in use cases to evaluate parameters such as disease progression and intervention efficacy. The featured speakers will discuss practical applications of precision motion sensor-based solutions to generate real-world data on patient functional mobility, and how it can influence patient’s perception of Quality of Life &amp; Activities of Daily Living impact.\r\nIn this webinar, the speakers will share clinical examples illustrating the selection and use of appropriate imaging studies and wearable sensors technology to capture performance outcome clinical outcome assessment (PerfO COA) in Parkinson’s disease and related central nervous system conditions including:[xtk_read_more]\r\n\r\n\r\n \tAdvances in neuroscience imaging and analysis that monitor disease progression, therapeutic efficacy, and characterize clinical findings in PD\r\n \tEnhancement of established PerfO outcome measures: the opportunity of wearable sensor technology to provide deeper insights to established COA in Parkinson’s disease trials\r\n \tThe role of mobility-related sensor technology in decentralized clinical trials: applications of wearable sensors in assessing efficacy and safety data within Parkinson’s disease\r\n \tHighlights of regulatory frameworks, industry Consortia groups’ positions or recommendations for evaluating and validating device-driven data capture and digital outcomes measures including validation to support clinical trial endpoints (for example, FDA, DIA, C-Path, DiMe and ISPOR)\r\n \tCase study examples:\r\n\r\n \tFindings from the field: discussion of sensor-derived data findings and the relationship to clinical outcome assessments in Parkinson’s disease\r\n \tClinical trial protocol development considerations: selecting a “wearables platform” — device parameters, data management, medical vs consumer-grade devices\r\n \tOutcome measure alignment to indication/disease severity considerations, access to technical &amp; clinical expertise in trial planning and conduct and data analysis\r\n\r\n\r\n \tLive Q&amp;A with panelists\r\n\r\n[/xtk_read_more]\r\n\r\nJoin the speakers as they share their experiences and insights on the key aspects of selection and analysis in clinical trial endpoints, including recent US Food and Drug Administration Digital Health Technology (FDA DHT) guidance and Clinical consortia collaboration on digital outcome measures, data quality management and the expanding role of wearable technology devices in decentralized and hybrid trials."
<https://xtalks.com/webinars/advances-in-precision-motion-and-imaging-clinical-trial-endpoints-collection-for-parkinsons-disease/>